Exodus Point Capital Management, LP Siga Technologies Inc Transaction History

Exodus Point Capital Management, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$5.0 - $6.31 $1.41 Million - $1.78 Million	281,663 Added 969.41%	310,718 $1.57 Million
Q1 2023 May 11, 2023	BUY	$5.23 - $8.42 $151,957 - $244,643	29,055 New	29,055 $167,000
Q3 2022 Nov 10, 2022	BUY	$10.02 - $26.15 $1.17 Million - $3.06 Million	117,074 New	117,074 $1.21 Million
Q1 2022 May 13, 2022	SELL	$5.96 - $7.61 $145,036 - $185,189	-24,335 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$6.96 - $9.26 $169,371 - $225,342	24,335 New	24,335 $183,000
Q3 2021 Nov 15, 2021	SELL	$5.71 - $7.39 $349,446 - $452,260	-61,199 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.1 - $7.58 $373,313 - $463,888	61,199 New	61,199 $384,000
Q4 2020 Feb 16, 2021	SELL	$6.39 - $7.76 $309,065 - $375,327	-48,367 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$5.62 - $7.68 $271,822 - $371,458	48,367 New	48,367 $332,000
Q4 2019 Feb 14, 2020	SELL	$4.34 - $5.86 $62,730 - $84,700	-14,454 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.93 - $5.8 $71,258 - $83,833	14,454 New	14,454 $74,000

184

35.6M

873K

466K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $434M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.